Related Experiment Video

Updated: Feb 25, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.2K

DNA methylation profiles in cancer diagnosis and therapeutics

Yunbao Pan1,2, Guohong Liu3,4, Fuling Zhou5

  • 1Department of Laboratory Medicine, Zhongnan Hospital, Wuhan University, No.169 Donghu Road, Wuchang District, Wuhan, 430071, China.

Clinical and Experimental Medicine
|July 29, 2017
PubMed

Insights

DNA methylation, an epigenetic mechanism, plays a key role in cancer. DNA methylation biomarkers show promise for cancer detection and treatment, but require further research for clinical application.

Area of Science:

  • Epigenetics and Cancer Biology
  • Molecular Oncology

Background:

  • Epigenetic modifications, including DNA methylation, are crucial in regulating cancer development.
  • DNA methylation, catalyzed by DNA methyltransferases (DNMTs), influences fundamental cellular processes like proliferation, apoptosis, and differentiation.
  • Recent advancements in epigenetics offer insights into tumorigenesis and potential cancer biomarkers.

Purpose of the Study:

  • To review the current status of DNA methylation biomarkers in cancer research.
  • To explore the potential of DNA methylation biomarkers for early detection, diagnosis, and prognosis.
  • To predict the future clinical utility of DNA methylation biomarkers in precision medicine.

Main Methods:

  • Literature review of current research on DNA methylation biomarkers.
  • Analysis of the role of DNA methylation in cancer initiation and proliferation.
  • Evaluation of the clinical potential and limitations of DNA methylation biomarkers.

Main Results:

  • DNA methylation is a significant epigenetic regulator in cancer.
  • DNA methylation biomarkers have demonstrated potential in cancer diagnostics and prognostics.
  • Clinical application of these biomarkers faces existing challenges and limitations.

Conclusions:

  • DNA methylation biomarkers hold considerable promise for advancing precision oncology.
  • Further research is necessary to overcome current limitations and facilitate clinical integration.
  • The future likely involves enhanced use of DNA methylation biomarkers in cancer management.
Keywords:
BiomarkerCancerDNA methylationDNMT inhibitorEpigenetics

More Related Videos

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

26.5K
Methyl-binding DNA capture Sequencing for Patient Tissues08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

9.1K

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.9K